"Spiramycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.
| Descriptor ID |
D015572
|
| MeSH Number(s) |
D02.540.576.500.999.725
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Spiramycin".
Below are MeSH descriptors whose meaning is more specific than "Spiramycin".
This graph shows the total number of publications written about "Spiramycin" by people in this website by year, and whether "Spiramycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Spiramycin" by people in Profiles.
-
A fresh look at the role of spiramycin in preventing a neglected disease: meta-analyses of observational studies. Eur J Med Res. 2021 Dec 11; 26(1):143.
-
Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol. 2003 Jun; 135(6):779-84.